Among the many words used to describe the current Chinese pharma market, from “hot” to “crowded” to "booming", the most common is “exciting.”
After all, China’s health sector has quickly emerged from the COVID-19 pandemic and is rebounding strongly, a fact underscored by the packed venues during the Drug Information Association China annual conference, one of the largest gatherings of top